Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 1/20 | 0.49 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.41 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.41 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.41 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.40 |
| ▸ | ADH1B | P00325 | 1/20 | 0.40 |
| ▸ | ADH1C | P00326 | 1/20 | 0.40 |
| ▸ | ADH1A | P07327 | 1/20 | 0.40 |
| ▸ | ADH4 | P08319 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8208326 | 1.00 | ANPEP (0.49) | ANPEPERAP2ALDH1A1TSHRUSP2 | |
| SCHEMBL3837850 | 1.00 | ANPEP (0.49) | ANPEPERAP2ALDH1A1TSHRUSP2 | |
| SCHEMBL7702560 | 1.00 | ANPEP (0.49) | ANPEPERAP2ALDH1A1TSHRUSP2 | |
| SCHEMBL28392997 | 1.00 | ANPEP (0.49) | ANPEPERAP2ALDH1A1TSHRUSP2 | |
| SCHEMBL24835020 | 1.00 | ANPEP (0.49) | ANPEPERAP2ALDH1A1TSHRUSP2 | |
| SCHEMBL6924948 | 1.00 | ANPEP (0.49) | ANPEPERAP2ALDH1A1TSHRUSP2 | |
| SCHEMBL24835071 | 1.00 | ANPEP (0.49) | ANPEPERAP2ALDH1A1TSHRUSP2 | |
| SCHEMBL28399146 | 1.00 | ANPEP (0.49) | ANPEPERAP2ALDH1A1TSHRUSP2 | |
| SCHEMBL9115910 | 1.00 | ANPEP (0.49) | ANPEPERAP2ALDH1A1TSHRUSP2 | |
| SCHEMBL3842331 | 1.00 | ANPEP (0.49) | ANPEPERAP2ALDH1A1TSHRUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001051767-A2 | ADDITION OF SOLIDS TO GENERATE VISCOSITY DOWNHOLE | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2001-07-19 | — | — | WO | claimed |
| US-10098841-B2 | Method of inducing a phase transition of a bilayer membrane vesicle | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2018-10-16 | — | — | US | disclosed |
| EP-1852177-B1 | MOLECULAR AGGREGATE CAPABLE OF UNDERGOING PHASE TRANSITION BY DEHYDRATING CONDENSATION AND METHOD OF PHASE TRANSITION THEREOF | JAPAN SCIENCE & TECH AGENCY (JP) | 2014-02-26 | — | — | EP | disclosed |
| EP-2669002-A1 | Molecular aggregate capable of undergoing phase transition by dehydrating condensation and method of phase transition thereof | Japan Science and Technology Agency (JP) | 2013-12-04 | — | — | EP | disclosed |
| US-20130251788-A1 | Method of Inducing a Phase Transition of a Bilayer Membrane Vesicle | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2013-09-26 | — | — | US | disclosed |
| US-20130251788-A1 | Method of Inducing a Phase Transition of a Bilayer Membrane Vesicle | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2013-09-26 | — | — | US | disclosed |
| CN-1942550-B | Viscoelastic acid | SCHLUMBERGER TECHNOLOGY BV | 2013-08-14 | — | — | CN | disclosed |
| US-8449979-B2 | Molecular aggregate capable of undergoing phase transition by dehydrating condensation and method of phase transition thereof | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2013-05-28 | — | — | US | disclosed |
| US-8449979-B2 | Molecular aggregate capable of undergoing phase transition by dehydrating condensation and method of phase transition thereof | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2013-05-28 | — | — | US | disclosed |
| EP-2430389-A1 | ARMOR | Milmark Technologies, Inc. (US) | 2012-03-21 | — | — | EP | disclosed |
| EP-1852177-A1 | MOLECULAR AGGREGATE CAPABLE OF UNDERGOING PHASE TRANSITION BY DEHYDRATING CONDENSATION AND METHOD OF PHASE TRANSITION THEREOF | Japan Science and Technology Agency (JP) | 2007-11-07 | — | — | EP | disclosed |
| EP-1852177-A1 | MOLECULAR AGGREGATE CAPABLE OF UNDERGOING PHASE TRANSITION BY DEHYDRATING CONDENSATION AND METHOD OF PHASE TRANSITION THEREOF | Japan Science and Technology Agency (JP) | 2007-11-07 | — | — | EP | disclosed |
| EP-1692242-B1 | VISCOELASTIC ACID | SCHLUMBERGER SERVICES PETROL (FR) | 2007-05-23 | — | — | EP | disclosed |
| CN-1942550-A | Viscoelastic acid | SCHLUMBERGER TECHNOLOGY BV (NL) | 2007-04-04 | — | — | CN | disclosed |
| EP-1692242-A1 | VISCOELASTIC ACID | Services Pétroliers Schlumberger (FR) | 2006-08-23 | — | — | EP | disclosed |
| WO-2005059059-A1 | VISCOELASTIC ACID | SCHLUMBERGER CANADA LIMITED (CA) | 2005-06-30 | — | — | WO | disclosed |
| EP-0711558-A1 | Compositions for topical application to skin, hair and nails | UNILEVER PLC (GB) | 1996-05-15 | — | — | EP | disclosed |
| US-5476661-A | Mixture of 25-hydroxycholecalciferol, a ceramide lipid, and a carrier; keratinocyte prodifferentiation, cosmetics | ELIZABETH ARDEN CO., DIVISION OF CONOPCO, INC. (US) | 1995-12-19 | — | — | US | disclosed |
| US-5476671-A | Skin disorders | CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO, INC. (US) | 1995-12-19 | — | — | US | disclosed |
| WO-1995016665-A1 | SYNTHETIC CERAMIDES AND THEIR USE IN COSMETIC COMPOSITIONS | UNILEVER PLC (GB) | 1995-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10098841-B2 | Method of inducing a phase transition of a bilayer membrane vesicle | VAPB, VAPA, NSF | ANPEP 4773/4885ERAP2 4659/4885ALDH1A1 2749/4885 |
| US-20130251788-A1 | Method of Inducing a Phase Transition of a Bilayer Membrane Vesicle | VAPB, VAPA, NSF | ANPEP 4773/4885ERAP2 4659/4885ALDH1A1 2749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.